These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 24632038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Paclitaxel-loaded N-octyl-O-sulfate chitosan micelles for superior cancer therapeutic efficacy and overcoming drug resistance.
    Jin X, Mo R, Ding Y, Zheng W, Zhang C.
    Mol Pharm; 2014 Jan 06; 11(1):145-57. PubMed ID: 24261922
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of TPGS-modified thermo-sensitive Pluronic PF127 hydrogel as a potential carrier to reverse the resistance of P-gp-overexpressing SMMC-7721 cell lines.
    Gao L, Wang X, Ma J, Hao D, Wei P, Zhou L, Liu G.
    Colloids Surf B Biointerfaces; 2016 Apr 01; 140():307-316. PubMed ID: 26764117
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.
    Bai F, Wang C, Lu Q, Zhao M, Ban FQ, Yu DH, Guan YY, Luan X, Liu YR, Chen HZ, Fang C.
    Biomaterials; 2013 Aug 01; 34(26):6163-74. PubMed ID: 23706689
    [Abstract] [Full Text] [Related]

  • 7. D-α-tocopherol polyethylene glycol succinate-based redox-sensitive paclitaxel prodrug for overcoming multidrug resistance in cancer cells.
    Bao Y, Guo Y, Zhuang X, Li D, Cheng B, Tan S, Zhang Z.
    Mol Pharm; 2014 Sep 02; 11(9):3196-209. PubMed ID: 25102234
    [Abstract] [Full Text] [Related]

  • 8. Encapsulated paclitaxel nanoparticles exhibit enhanced anti-tumor efficacy in A549 non-small lung cancer cells.
    Huang G, Zang B, Wang X, Liu G, Zhao J.
    Acta Biochim Biophys Sin (Shanghai); 2015 Dec 02; 47(12):981-7. PubMed ID: 26525950
    [Abstract] [Full Text] [Related]

  • 9. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F, Wang X, Xu X, Li M, Zhou J, Wang W.
    Eur J Pharm Sci; 2016 Sep 20; 92():11-21. PubMed ID: 27343697
    [Abstract] [Full Text] [Related]

  • 10. Systematic evaluation of multifunctional paclitaxel-loaded polymeric mixed micelles as a potential anticancer remedy to overcome multidrug resistance.
    Zhang J, Zhao X, Chen Q, Yin X, Xin X, Li K, Qiao M, Hu H, Chen D, Zhao X.
    Acta Biomater; 2017 Mar 01; 50():381-395. PubMed ID: 27956367
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Nanohybrid systems of non-ionic surfactant inserting liposomes loading paclitaxel for reversal of multidrug resistance.
    Ji X, Gao Y, Chen L, Zhang Z, Deng Y, Li Y.
    Int J Pharm; 2012 Jan 17; 422(1-2):390-7. PubMed ID: 22001531
    [Abstract] [Full Text] [Related]

  • 14. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C, Guo LB, Ma JY, Li YM, Liu HM.
    Int J Oncol; 2013 Nov 17; 43(5):1607-17. PubMed ID: 24002547
    [Abstract] [Full Text] [Related]

  • 15. Reversal of P-gp-mediated multidrug resistance by Bromotetrandrine in vivo is associated with enhanced accumulation of chemotherapeutical drug in tumor tissue.
    Chen LM, Liang YJ, Zhang X, Su XD, Dai CL, Wang FP, Yan YY, Tao LY, Fu LW.
    Anticancer Res; 2009 Nov 17; 29(11):4597-604. PubMed ID: 20032409
    [Abstract] [Full Text] [Related]

  • 16. IF7-Conjugated Nanoparticles Target Annexin 1 of Tumor Vasculature against P-gp Mediated Multidrug Resistance.
    Yu DH, Liu YR, Luan X, Liu HJ, Gao YG, Wu H, Fang C, Chen HZ.
    Bioconjug Chem; 2015 Aug 19; 26(8):1702-12. PubMed ID: 26076081
    [Abstract] [Full Text] [Related]

  • 17. Redox-sensitive mPEG-SS-PTX/TPGS mixed micelles: An efficient drug delivery system for overcoming multidrug resistance.
    Zhao D, Zhang H, Yang S, He W, Luan Y.
    Int J Pharm; 2016 Dec 30; 515(1-2):281-292. PubMed ID: 27746331
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel.
    Zhu X, Sui M, Fan W.
    Anticancer Res; 2005 Dec 30; 25(3B):1953-62. PubMed ID: 16158930
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of mdr1 by G-quadruplex oligonucleotides and reversal of paclitaxel resistance in human ovarian cancer cells.
    Wang B, Li S, Meng X, Shang H, Guan Y.
    Tumour Biol; 2015 Aug 30; 36(8):6433-43. PubMed ID: 25801244
    [Abstract] [Full Text] [Related]

  • 20. Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition.
    Meng L, Xia X, Yang Y, Ye J, Dong W, Ma P, Jin Y, Liu Y.
    Int J Pharm; 2016 Nov 20; 513(1-2):8-16. PubMed ID: 27596118
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.